Syros Pharmaceuticals Inc logo

Syros Pharmaceuticals Inc

NAS:SYRS (USA)  
$ 5.77 -0.26 (-4.29%) 11:09 PM EST
At Loss
P/B:
10.36
Market Cap:
$ 154.22M
Enterprise V:
$ 115.34M
Volume:
46.88K
Avg Vol (2M):
93.70K
Trade In:
Volume:
46.88K
At Loss
Avg Vol (2M):
93.70K

Business Description

Description
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Name Current Vs Industry Vs History
Cash-To-Debt 1.76
Equity-to-Asset 0.11
Debt-to-Equity 4.1
Debt-to-EBITDA -0.45
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.43
Distress
Grey
Safe
Beneish M-Score -4.84
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36.55
9-Day RSI 46.67
14-Day RSI 50.28
6-1 Month Momentum % -12.37
12-1 Month Momentum % 67.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.01
Quick Ratio 3.01
Cash Ratio 2.9

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -67.6
Shareholder Yield % 0.97

Financials (Next Earnings Date:2024-08-08 Est.)

SYRS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SYRS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Syros Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6.981
EPS (TTM) ($) -5.05
Beta 1.38
Volatility % 194.8
14-Day RSI 50.28
14-Day ATR ($) 0.368266
20-Day SMA ($) 5.7125
12-1 Month Momentum % 67.92
52-Week Range ($) 2.0902 - 8.17
Shares Outstanding (Mil) 26.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Syros Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Syros Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Syros Pharmaceuticals Inc Frequently Asked Questions

What is Syros Pharmaceuticals Inc(SYRS)'s stock price today?
The current price of SYRS is $5.77. The 52 week high of SYRS is $8.17 and 52 week low is $2.09.
When is next earnings date of Syros Pharmaceuticals Inc(SYRS)?
The next earnings date of Syros Pharmaceuticals Inc(SYRS) is 2024-08-08 Est..
Does Syros Pharmaceuticals Inc(SYRS) pay dividends? If so, how much?
Syros Pharmaceuticals Inc(SYRS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1